C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction

被引:35
|
作者
Magro, CM
Abbas, AE
Seilstad, K
Pope-Harman, AL
Nadasdy, T
Ross, P
机构
[1] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Surg, Div Cardiothorac Surg, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Columbus, OH 43210 USA
关键词
lung transplantation; C3d deposition; chronic graft dysfunction;
D O I
10.1016/j.humimm.2005.11.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Studies have shown a potential role for humoral rejection in the evolution of lung graft dysfunction, apparently based on antibodies without human leukocyte antigen specificity. The correlation between extent of C4d deposition with clinical status further illustrates the importance of humoral immunity. Our study examines the potential value of C3d as a further diagnostic adjunct. C3d deposition was examined in lung allograft specimens using frozen tissue indirect direct immunofluorescence (IIF) and avidin biotin immunohistochemical applied to paraffin embedded tissue. Intermediate/extensive amounts of C3d using 1117 and immunohistochemical (IH) methodologies correlated with chronic graft dysfunction; IIF C3d deposition was associated with septal and bronchial wall fibrosis (p < 0.0001). Weak/absent amounts of IIF and IH C3d correlated with clinical stability (p < 0.0001). Higher levels of C3d by IH were more sensitive than by IN as a bronchiotitis obliterans syndrome determinant. C3d and C4d deposition using immunofluorescence and IH were correlated (p < 0.00001). C3d deposition appears prognostically significant. Higher tissue expression of C3d mark chronic graft dysfunction/persistent graft failure following transplantation. The close correlation between C3d and C4d lends credence to the role of humoral allograft rejection as a pulmonary graft dysfunction contributing factor. C3d by IH manifests higher sensitivity but similar specificity compared to C3d by IIF.
引用
收藏
页码:274 / 283
页数:10
相关论文
共 50 条
  • [41] Chronic lung allograft dysfunction: evolving practice
    Vos, Robin
    Verleden, Stijn E.
    Verleden, Geert M.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2015, 20 (05) : 483 - 491
  • [42] Airway Alterations in Chronic Lung Allograft Dysfunction
    Verleden, S. E.
    Vasilescu, D.
    Willems, S.
    Ruttens, D.
    Vos, R.
    Vandermeulen, E.
    Mcdonough, J.
    Verbeken, E.
    Verschakelen, J.
    Van Raemdonck, D.
    Rondelet, B.
    Knoop, C.
    Decramer, M.
    Cooper, J.
    Hogg, J.
    Hostens, J.
    Verleden, G.
    Vanaudenaerde, B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S105 - S106
  • [43] Transglutaminase 2 in Chronic Lung Allograft Dysfunction
    Tissot, A.
    Brouard, S.
    Berthelot, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S512 - S512
  • [44] Emerging biomarkers in chronic lung allograft dysfunction
    Shtraichman, Osnat
    Diamond, Joshua M.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (05) : 467 - 475
  • [45] Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
    Veraar, Cecilia
    Kliman, Jonathan
    Benazzo, Alberto
    Oberndorfer, Felicitas
    Laggner, Maria
    Hacker, Philipp
    Raunegger, Thomas
    Janik, Stefan
    Jaksch, Peter
    Klepetko, Walter
    Ankersmit, Hendrik J.
    Moser, Bernhard
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [46] Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
    Cecilia Veraar
    Jonathan Kliman
    Alberto Benazzo
    Felicitas Oberndorfer
    Maria Laggner
    Philipp Hacker
    Thomas Raunegger
    Stefan Janik
    Peter Jaksch
    Walter Klepetko
    Hendrik J. Ankersmit
    Bernhard Moser
    Scientific Reports, 11
  • [47] MEASUREMENTS OF SERUM C3D IN PRIMITIVE CHRONIC GLOMERULAR NEPHROPATHIES
    LAGRUE, G
    BRANELLEC, A
    INTRATOR, L
    MOISY, M
    SOBEL, A
    NOUVELLE PRESSE MEDICALE, 1979, 8 (14): : 1153 - 1156
  • [48] Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction
    Wong, Wai
    Johnson, Brandy
    Cheng, Pi Chun
    Josephson, Maureen B.
    Maeda, Katsuhide
    Berg, Robert A.
    Kawut, Steven M.
    Harhay, Michael O.
    Goldfarb, Samuel B.
    Yehya, Nadir
    Himebauch, Adam S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (05): : 669 - 678
  • [49] Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
    Iturbe-Fernandez, David
    Gafas, Alicia de Pablo
    Cuesta, Victor Manuel Mora
    Moralejo, Rodrigo Alonso
    Loaiza, Carlos Andres Quezada
    Perez Gonzalez, Virginia
    Lopez-Padilla, Daniel
    Cifrian, Jose M.
    LIFE-BASEL, 2024, 14 (05):
  • [50] Montelukast in chronic lung allograft dysfunction after lung transplantation
    Vos, Robin
    Vanden Eynde, Ruben
    Ruttens, David
    Verleden, Stijn E.
    Vanaudenaerde, Bart M.
    Dupont, Lieven J.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Neyrinck, Arne P.
    Van Raemdonck, Dirk E.
    Verleden, Geert M.
    Godinas, Laurent
    Van Herck, Anke
    Vanstapel, Arno
    Sacreas, Annelore
    Kaes, Janne
    Heigl, Tobias
    Ordies, Sofie
    Schaevers, Veronique
    De Leyn, Paul
    Coosemans, Willy
    Nafteux, Philippe
    Decaluwe, Herbert
    Van Veer, Hans
    Depypere, Lieven
    Frick, Anna E.
    Ceulemans, Laurens J.
    Weynand, Birgit
    Emonds, Marie-Paule
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05): : 516 - 527